| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/HJR.0B013E3283213108 |
| P8608 | Fatcat ID | release_w2ccwu7lyfaangjec5r7jmoshm |
| P698 | PubMed publication ID | 19387352 |
| P50 | author | Johan Sundström | Q44445324 |
| Lars Lind | Q65992534 | ||
| Johannes Hulthe | Q114370998 | ||
| P2093 | author name string | Jonas Hansson | |
| P2860 | cites work | Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation | Q33212490 |
| Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community | Q35207721 | ||
| Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. | Q35580538 | ||
| Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events | Q36366342 | ||
| Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. | Q43882421 | ||
| TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension | Q44087061 | ||
| Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels | Q44397633 | ||
| Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study | Q45040591 | ||
| Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study | Q46954419 | ||
| Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study | Q47406734 | ||
| Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure | Q48482082 | ||
| Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. | Q52429603 | ||
| Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy | Q57532680 | ||
| P433 | issue | 3 | |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 297-303 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | European Journal of Cardiovascular Prevention and Rehabilitation | Q2766064 |
| P1476 | title | Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study | |
| P478 | volume | 16 |
| Q38005590 | Arterial stiffness and pulse pressure in CKD and ESRD. |
| Q64071126 | Association of Circulating Tissue Inhibitor of Metalloproteinases-1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease |
| Q36449881 | Biochemical markers of aging for longitudinal studies in humans |
| Q33809526 | Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study |
| Q34794044 | Correlation of circulating MMP-9 with white blood cell count in humans: effect of smoking |
| Q64067406 | Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure |
| Q38102723 | Evidence that periodontal treatment improves biomarkers and CVD outcomes |
| Q51029740 | Evidence that periodontal treatment improves biomarkers and CVD outcomes. |
| Q38761728 | Fentanyl inhibits the progression of human gastric carcinoma MGC-803 cells by modulating NF-κB-dependent gene expression in vivo |
| Q34181580 | Hemodialysis removes uremic toxins that alter the biological actions of endothelial cells |
| Q51042519 | Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort. |
| Q34505861 | Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment |
| Q93099741 | Mechanisms of cardiac collagen deposition in experimental models and human disease |
| Q34690957 | Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis |
| Q37964006 | Novel effects of macrolide antibiotics on cardiovascular diseases |
| Q36291589 | Physical versus psychological social stress in male rats reveals distinct cardiovascular, inflammatory and behavioral consequences |
| Q64967712 | Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production. |
| Q34222299 | Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality |
| Q48207488 | Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus. |
| Q38120572 | TIMP-1 polymorphisms in a Chinese Han population with intracerebral hemorrhage |
| Q49649299 | Urine Arsenic and Arsenic Metabolites in U.S. Adults and Biomarkers of Inflammation, Oxidative Stress, and Endothelial Dysfunction: A Cross-Sectional Study |
| Q47734987 | Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease |
Search more.